Cargando…

Linkage of the CHHiP randomised controlled trial with primary care data: a study investigating ways of supplementing cancer trials and improving evidence-based practice

BACKGROUND: Randomised controlled trials (RCTs) are the gold standard for evidence-based practice. However, RCTs can have limitations. For example, translation of findings into practice can be limited by design features, such as inclusion criteria, not accurately reflecting clinical populations. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemanska, Agnieszka, Byford, Rachel C., Cruickshank, Clare, Dearnaley, David P., Ferreira, Filipa, Griffin, Clare, Hall, Emma, Hinton, William, de Lusignan, Simon, Sherlock, Julian, Faithfull, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382082/
https://www.ncbi.nlm.nih.gov/pubmed/32711460
http://dx.doi.org/10.1186/s12874-020-01078-9
_version_ 1783563180283265024
author Lemanska, Agnieszka
Byford, Rachel C.
Cruickshank, Clare
Dearnaley, David P.
Ferreira, Filipa
Griffin, Clare
Hall, Emma
Hinton, William
de Lusignan, Simon
Sherlock, Julian
Faithfull, Sara
author_facet Lemanska, Agnieszka
Byford, Rachel C.
Cruickshank, Clare
Dearnaley, David P.
Ferreira, Filipa
Griffin, Clare
Hall, Emma
Hinton, William
de Lusignan, Simon
Sherlock, Julian
Faithfull, Sara
author_sort Lemanska, Agnieszka
collection PubMed
description BACKGROUND: Randomised controlled trials (RCTs) are the gold standard for evidence-based practice. However, RCTs can have limitations. For example, translation of findings into practice can be limited by design features, such as inclusion criteria, not accurately reflecting clinical populations. In addition, it is expensive to recruit and follow-up participants in RCTs. Linkage with routinely collected data could offer a cost-effective way to enhance the conduct and generalisability of RCTs. The aim of this study is to investigate how primary care data can support RCTs. METHODS: Secondary analysis following linkage of two datasets: 1) multicentre CHHiP radiotherapy trial (ISRCTN97182923) and 2) primary care database from the Royal College of General Practitioners Research and Surveillance Centre. Comorbidities and medications recorded in CHHiP at baseline, and radiotherapy-related toxicity recorded in CHHiP over time were compared with primary care records. The association of comorbidities and medications with toxicity was analysed with mixed-effects logistic regression. RESULTS: Primary care records were extracted for 106 out of 2811 CHHiP participants recruited from sites in England (median age 70, range 44 to 82). Complementary information included longitudinal body mass index, blood pressure and cholesterol, as well as baseline smoking and alcohol usage but was limited by the considerable missing data. In the linked sample, 9 (8%) participants were recorded in CHHiP as having a history of diabetes and 38 (36%) hypertension, whereas primary care records indicated incidence prior to trial entry of 11 (10%) and 40 (38%) respectively. Concomitant medications were not collected in CHHiP but available in primary care records. This indicated that 44 (41.5%) men took aspirin, 65 (61.3%) statins, 14 (13.2%) metformin and 46 (43.4%) phosphodiesterase-5-inhibitors at some point before or after trial entry. CONCLUSIONS: We provide a set of recommendations on linkage and supplementation of trials. Data recorded in primary care are a rich resource and linkage could provide near real-time information to supplement trials and an efficient and cost-effective mechanism for long-term follow-up. In addition, standardised primary care data extracts could form part of RCT recruitment and conduct. However, this is at present limited by the variable quality and fragmentation of primary care data.
format Online
Article
Text
id pubmed-7382082
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73820822020-07-27 Linkage of the CHHiP randomised controlled trial with primary care data: a study investigating ways of supplementing cancer trials and improving evidence-based practice Lemanska, Agnieszka Byford, Rachel C. Cruickshank, Clare Dearnaley, David P. Ferreira, Filipa Griffin, Clare Hall, Emma Hinton, William de Lusignan, Simon Sherlock, Julian Faithfull, Sara BMC Med Res Methodol Research Article BACKGROUND: Randomised controlled trials (RCTs) are the gold standard for evidence-based practice. However, RCTs can have limitations. For example, translation of findings into practice can be limited by design features, such as inclusion criteria, not accurately reflecting clinical populations. In addition, it is expensive to recruit and follow-up participants in RCTs. Linkage with routinely collected data could offer a cost-effective way to enhance the conduct and generalisability of RCTs. The aim of this study is to investigate how primary care data can support RCTs. METHODS: Secondary analysis following linkage of two datasets: 1) multicentre CHHiP radiotherapy trial (ISRCTN97182923) and 2) primary care database from the Royal College of General Practitioners Research and Surveillance Centre. Comorbidities and medications recorded in CHHiP at baseline, and radiotherapy-related toxicity recorded in CHHiP over time were compared with primary care records. The association of comorbidities and medications with toxicity was analysed with mixed-effects logistic regression. RESULTS: Primary care records were extracted for 106 out of 2811 CHHiP participants recruited from sites in England (median age 70, range 44 to 82). Complementary information included longitudinal body mass index, blood pressure and cholesterol, as well as baseline smoking and alcohol usage but was limited by the considerable missing data. In the linked sample, 9 (8%) participants were recorded in CHHiP as having a history of diabetes and 38 (36%) hypertension, whereas primary care records indicated incidence prior to trial entry of 11 (10%) and 40 (38%) respectively. Concomitant medications were not collected in CHHiP but available in primary care records. This indicated that 44 (41.5%) men took aspirin, 65 (61.3%) statins, 14 (13.2%) metformin and 46 (43.4%) phosphodiesterase-5-inhibitors at some point before or after trial entry. CONCLUSIONS: We provide a set of recommendations on linkage and supplementation of trials. Data recorded in primary care are a rich resource and linkage could provide near real-time information to supplement trials and an efficient and cost-effective mechanism for long-term follow-up. In addition, standardised primary care data extracts could form part of RCT recruitment and conduct. However, this is at present limited by the variable quality and fragmentation of primary care data. BioMed Central 2020-07-25 /pmc/articles/PMC7382082/ /pubmed/32711460 http://dx.doi.org/10.1186/s12874-020-01078-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Lemanska, Agnieszka
Byford, Rachel C.
Cruickshank, Clare
Dearnaley, David P.
Ferreira, Filipa
Griffin, Clare
Hall, Emma
Hinton, William
de Lusignan, Simon
Sherlock, Julian
Faithfull, Sara
Linkage of the CHHiP randomised controlled trial with primary care data: a study investigating ways of supplementing cancer trials and improving evidence-based practice
title Linkage of the CHHiP randomised controlled trial with primary care data: a study investigating ways of supplementing cancer trials and improving evidence-based practice
title_full Linkage of the CHHiP randomised controlled trial with primary care data: a study investigating ways of supplementing cancer trials and improving evidence-based practice
title_fullStr Linkage of the CHHiP randomised controlled trial with primary care data: a study investigating ways of supplementing cancer trials and improving evidence-based practice
title_full_unstemmed Linkage of the CHHiP randomised controlled trial with primary care data: a study investigating ways of supplementing cancer trials and improving evidence-based practice
title_short Linkage of the CHHiP randomised controlled trial with primary care data: a study investigating ways of supplementing cancer trials and improving evidence-based practice
title_sort linkage of the chhip randomised controlled trial with primary care data: a study investigating ways of supplementing cancer trials and improving evidence-based practice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382082/
https://www.ncbi.nlm.nih.gov/pubmed/32711460
http://dx.doi.org/10.1186/s12874-020-01078-9
work_keys_str_mv AT lemanskaagnieszka linkageofthechhiprandomisedcontrolledtrialwithprimarycaredataastudyinvestigatingwaysofsupplementingcancertrialsandimprovingevidencebasedpractice
AT byfordrachelc linkageofthechhiprandomisedcontrolledtrialwithprimarycaredataastudyinvestigatingwaysofsupplementingcancertrialsandimprovingevidencebasedpractice
AT cruickshankclare linkageofthechhiprandomisedcontrolledtrialwithprimarycaredataastudyinvestigatingwaysofsupplementingcancertrialsandimprovingevidencebasedpractice
AT dearnaleydavidp linkageofthechhiprandomisedcontrolledtrialwithprimarycaredataastudyinvestigatingwaysofsupplementingcancertrialsandimprovingevidencebasedpractice
AT ferreirafilipa linkageofthechhiprandomisedcontrolledtrialwithprimarycaredataastudyinvestigatingwaysofsupplementingcancertrialsandimprovingevidencebasedpractice
AT griffinclare linkageofthechhiprandomisedcontrolledtrialwithprimarycaredataastudyinvestigatingwaysofsupplementingcancertrialsandimprovingevidencebasedpractice
AT hallemma linkageofthechhiprandomisedcontrolledtrialwithprimarycaredataastudyinvestigatingwaysofsupplementingcancertrialsandimprovingevidencebasedpractice
AT hintonwilliam linkageofthechhiprandomisedcontrolledtrialwithprimarycaredataastudyinvestigatingwaysofsupplementingcancertrialsandimprovingevidencebasedpractice
AT delusignansimon linkageofthechhiprandomisedcontrolledtrialwithprimarycaredataastudyinvestigatingwaysofsupplementingcancertrialsandimprovingevidencebasedpractice
AT sherlockjulian linkageofthechhiprandomisedcontrolledtrialwithprimarycaredataastudyinvestigatingwaysofsupplementingcancertrialsandimprovingevidencebasedpractice
AT faithfullsara linkageofthechhiprandomisedcontrolledtrialwithprimarycaredataastudyinvestigatingwaysofsupplementingcancertrialsandimprovingevidencebasedpractice